Back to Results
First PageMeta Content
Transfusion medicine / Medicine / Behring / Dividend / Plasmapheresis / Biology / CSL Behring / CSL Limited / Canada Steamship Lines


CSL LIMITED ANNUAL REPORT[removed] CSL Limited ABN[removed]Annual Report[removed]
Add to Reading List

Document Date: 2012-09-13 19:56:42

Open Document

File Size: 4,47 MB

Share Result on Facebook

City

Bern / Kankakee / TOKYO / MELBOURNE / Broadmeadows / /

Company

Continued cSl biotheraPieS SaleS / CSL G North America / PARKVILLE CSL Limited / Plasma Testing Laboratory / cSl behrinG SaleS / Agency for Privigen / Cardinal Healthcare China / CSL Group / CSL Biotherapies / The CSL Limited / Batman Avenue Melbourne 3000 Computershare Investor Services Pty Limited / /

Continent

Asia / North America / Europe / /

Country

Taiwan / Germany / Switzerland / New Zealand / Malaysia / Japan / United States / Australia / United Kingdom / China / Singapore / /

Currency

cent / USD / /

Event

General or Shareholder Meeting / FDA Phase / Dividend Issuance / Security Buyback / Company Expansion / /

Facility

National Tennis Centre / KNOXVILLE US CSL Plasma Testing Laboratory / Broadmeadows facility / /

IndustryTerm

manufacturing facility / treatment of multiple sclerosis / fractionation services / pharmaceutical industry / treatment of coagulation disorders / Manufacturing methods / life cycle management / manufacturing facilities / logistics supplier / therapies for cancer / manufacturing products / product / substantial manufacturing operations / higher concentration product / cell culture biotechnology facility / clinical study protocol / biopharmaceutical / manufacturing infrastructure / market immunohaematology products / manufacturing areas / manufacturing network / prevention of cholera / manufacturing site / pharmaceutical products / quality products / prescription pharmaceutical products / intravenous immunoglobulin manufacturing facility / /

MedicalCondition

haemophilia / hereditary angioedema / multiple sclerosis / haemolytic disease / influenza / orphan diseases / primary immune deficiency / cancer / coagulation disorders / shock / seasonal and pandemic influenza / cholera / von Willebrand disease / infection / inflammation / further advance hereditary angioedema treatment / respiratory disease / disorders / /

MedicalTreatment

self administration / organ transplants / innovative therapies / heart surgery / /

NaturalFeature

Computershare Investor Services Pty Limited Yarra Falls / /

Organization

Food and Drug Administration / Medicines and Medical Devices Safety Authority / KNOXVILLE US CSL Plasma Testing Laboratory / Therapeutic Goods Administration / European Medicines Agency for Privigen / National Blood Authority / KING OF PRUSSIA US CSL Behring Administration / INDIANAPOLIS US CSL Plasma Logistics Centre / Function Centre / /

Person

McnaMee / John Shine / /

Position

driver / personal digital assistant / MAJOR PRODuCTS / ao ChAirmAn / ChieF exeCutive oFFiCer And mAnAGinG direCtor / General / ao ChieF / general corporate purposes / ProFeSSor / aSia PaciFic leader / Annual General / direCtor The benefit / /

Product

Copaxone / Evogam® / Hizentra® / Privigen® / /

ProvinceOrState

Illinois / Newfoundland / /

Region

Latin America / Asia Pacific / /

Technology

biotechnology / personal digital assistant / clinical study protocol / recombinant DNA technology / /

URL

www.csl.com.au / /

SocialTag